Subchondral treatment of joint pain of the spine

US9402670B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9402670-B2
Application numberUS-201514862887-A
CountryUS
Kind codeB2
Filing dateSep 23, 2015
Priority dateAug 7, 2011
Publication dateAug 2, 2016
Grant dateAug 2, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Methods for altering the natural history of degenerative disc disease and osteoarthritis of the spine are proposed. The methods focus on the prevention, or delayed onset or progression of, subchondral defects such as bone marrow edema or bone marrow lesion, and subchondral treatment to prevent the progression of osteoarthritis or degenerative disc disease in the spine and thereby treat pain.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of reinforcing bone located in a targeted bone marrow lesion (BML) in a subchondral region of a vertebral body for treating the targeted bone marrow lesion, the method comprising: identifying a bone marrow lesion in a subchondral region of a vertebral body so as to establish a targeted bone marrow lesion for receiving treatment, the vertebral body including a superior vertebral endplate with a superior articular surface and an inferior vertebral endplate with an inferior articular surface, wherein said identifying includes identifying with MRI; creating, in the vertebral body that contains the targeted bone marrow lesion in the subchondral region, a subchondral injection path to an area in and/or adjacent to the targeted bone marrow lesion for injecting an injectable bone filling material into said area for reinforcing bone located in the targeted bone marrow lesion, wherein said creating preserves an existing condition of the superior articular surface of the vertebral body and an existing condition of the inferior articular surface of the vertebral body; and injecting an injectable and curable bone filling material into said area via the subchondral injection path, wherein the injectable bone filling material is a bone reinforcing material that is left in the area for hardening in the area so as to form, in situ, a bone reinforcing member for reinforcing bone located in the targeted bone marrow lesion, wherein the injectable bone filling material is left in the area without also delivering and leaving a structural implant device in and/or adjacent to the targeted bone marrow lesion in addition to the injectable bone filling material. 2. The method of claim 1 , wherein said creating is conducted without further creating a void in or adjacent to the targeted bone marrow lesion. 3. The method of claim 1 , wherein the injectable bone filling material envelopes the targeted bone marrow lesion. 4. The method of claim 1 , wherein said creating is performed percutaneously. 5. The method of claim 1 , wherein said creating is performed arthroscopically. 6. The method of claim 1 , wherein the subchondral region occurs in a facet. 7. The method of claim 1 , wherein the subchondral injection path is created with a needle. 8. The method of claim 1 , wherein said area is in the targeted bone marrow lesion. 9. A method of reinforcing bone located in a targeted bone marrow lesion (BML) in a subchondral region of a vertebral body for treating the targeted bone marrow lesion, the method comprising: identifying a bone marrow lesion in a subchondral region of a vertebral body so as to establish a targeted bone marrow lesion for receiving treatment, the vertebral body including a superior vertebral endplate with a superior articular surface and an inferior vertebral endplate with an inferior articular surface, wherein said identifying includes identifying with MRI; creating, in the vertebral body that contains the targeted bone marrow lesion in the subchondral region, a subchondral injection path to an area in and/or adjacent to the targeted bone marrow lesion for injecting an injectable bone filling material into said area for reinforcing bone located in the targeted bone marrow lesion, wherein said creating preserves an existing condition of the superior articular surface of the vertebral body and an existing condition of the inferior articular surface of the vertebral body; and injecting an injectable and curable bone filling material into said area via the subchondral injection path, wherein the injectable bone filling material is a bone reinforcing material that is left in the area for hardening in the area so as to form, in situ, a bone reinforcing member for reinforcing bone located in the targeted bone marrow lesion, wherein the injectable bone filling material envelopes the targeted bone marrow lesion, and wherein the injectable bone filling material is left in the area without also delivering and leaving a structural implant device in and/or adjacent to the targeted bone marrow lesion in addition to the injectable bone filling material. 10. The method of claim 9 , wherein said creating is conducted without further creating a void in or adjacent to the targeted bone marrow lesion. 11. The method of claim 9 , wherein said creating is performed percutaneously. 12. The method of claim 9 , wherein said creating is performed arthroscopically. 13. The method of claim 9 , wherein the subchondral region occurs in a facet. 14. The method of claim 9 , wherein the subchondral injection path is created with a needle. 15. The method of claim 9 , wherein said area is in the targeted bone marrow lesion. 16. A method of reinforcing bone located in a targeted bone marrow lesion (BML) in a subchondral region of a vertebral body for treating the targeted bone marrow lesion, the method comprising: identifying a bone marrow lesion in a subchondral region of a vertebral body so as to establish a targeted bone marrow lesion for receiving treatment, the vertebral body including a superior vertebral endplate with a superior articular surface and an inferior vertebral endplate with an inferior articular surface, wherein said identifying includes identifying with MRI; creating, in the vertebral body that contains the targeted bone marrow lesion in the subchondral region, a subchondral injection path to an area in and/or adjacent to the targeted bone marrow lesion for injecting an injectable bone filling material into said area for reinforcing bone located in the targeted bone marrow lesion, wherein said creating preserves an existing condition of the superior articular surface of the vertebral body and an existing condition of the inferior articular surface of the vertebral body, and is conducted without further creating a void in or adjacent to the targeted bone marrow lesion; and injecting an injectable and curable bone filling material into said area via the subchondral injection path, wherein the injectable bone filling material is a bone reinforcing material that is left in the area for hardening in the area so as to form, in situ, a bone reinforcing member for reinforcing bone located in the targeted bone marrow lesion, wherein the injectable bone filling material envelopes the targeted bone marrow lesion. 17. The method of claim 16 , wherein the subchondral region occurs in a facet. 18. The method of claim 16 , wherein said area is in the targeted bone marrow lesion. 19. The method of claim 16 , wherein said creating is performed percutaneously. 20. The method of claim 16 , wherein the subchondral injection path is created with a needle.

Assignees

Inventors

Classifications

  • Designing or manufacturing processes · CPC title

  • differing in porosity · CPC title

  • differing in absorbability or resorbability, i.e. in absorption or resorption time · CPC title

  • soldered or brazed or welded · CPC title

  • Flowable or injectable implant compositions · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9402670B2 cover?
Methods for altering the natural history of degenerative disc disease and osteoarthritis of the spine are proposed. The methods focus on the prevention, or delayed onset or progression of, subchondral defects such as bone marrow edema or bone marrow lesion, and subchondral treatment to prevent the progression of osteoarthritis or degenerative disc disease in the spine and thereby treat pain.
Who is the assignee on this patent?
Zimmer Knee Creations Inc
What technology area does this patent fall under?
Primary CPC classification A61F2/4405. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Aug 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).